LAHSER, FREDERICK C.,拉瑟 弗德瑞克C,拉瑟 弗德瑞克C,GU, ZHENGXIAN,古正贤,古正賢
申请号：
TW099110614
公开号：
TWI414288B
申请日:
2010.04.06
申请国别(地区):
TW
年份:
2013
代理人:
摘要：
The present invention is directed to a combination product for treating or ameliorating hepatitis C virus (HCV) infection or disorders or symptoms associated therewith in a subject in need thereof comprising, a HCV inhibitor and one or more therapeutic agents selected from either or both a HCV protease inhibitor and one or more different therapeutic agents administered in combination in an effective amount to the subject.本發明係有關一種為有需要之個體治療或改善C型肝炎病毒(HCV)感染或與其相關之病症或症狀的組合產品,其包括對個體組合投與有效量之HCV抑制劑及一或多種治療劑,該一或多種治療劑係選自HCV蛋白酶抑制劑及一或多種不同治療劑中的一者或兩者。The present invention is directed to a combination product for treating or ameliorating hepatitis C virus (HCV) infection or disorders or symptoms associated therewith in a subject in need thereof comprising, a HCV inhibitor and one or more therapeutic agents selected from either or both a HCV protease inhibitor and one or more different therapeutic agents administered in combination in an effective amount to the subject.
